Artiva Biotherapeutics, Inc. ARTV Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Artiva Biotherapeutics, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Artiva Biotherapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s total debt?
- Artiva Biotherapeutics, Inc. (ARTV) reported total debt of $10.26M in Q1 2026.
- How has Artiva Biotherapeutics, Inc.'s total debt changed year-over-year?
- Artiva Biotherapeutics, Inc.'s total debt decreased by 26.7% year-over-year, from $14M to $10.26M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s total debt?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s total debt has grown at a -19.6% compound annual growth rate (CAGR), from $16.91M to $10.94M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.